Ronald Harold Wilfred Cooper - Apr 22, 2022 Form 4 Insider Report for ALBIREO PHARMA, INC. (ALBO)

Role
President and CEO, Director
Signature
/s/ Jason Duncan, Attorney-in-fact
Stock symbol
ALBO
Transactions as of
Apr 22, 2022
Transactions value $
-$30,031
Form type
4
Date filed
4/25/2022, 04:40 PM
Previous filing
Jan 25, 2022
Next filing
Jun 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALBO Common Stock Sale -$30K -907 -1.59% $33.11 56.1K Apr 22, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F2 Represents 22,600 shares of common stock and 33,482 restricted stock units.